David Aebisher
Overview
Explore the profile of David Aebisher including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
106
Citations
751
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Klosowicz M, Leksa D, Bartusik-Aebisher D, Mysliwiec A, Dynarowicz K, Aebisher D
Curr Issues Mol Biol
. 2024 Sep;
46(9):9503-9522.
PMID: 39329916
Atherosclerosis is a chronic inflammatory disease that causes degenerative and productive changes in the arteries. The resulting atherosclerotic plaques restrict the vessel lumen, causing blood flow disturbances. Plaques are formed...
12.
Zolyniak-Brzuchacz A, Barnas E, Bartusik-Aebisher D, Aebisher D
Int J Mol Sci
. 2024 Aug;
25(16).
PMID: 39201458
Endometrial cancer is the most common malignant tumor of the female reproductive system. It develops in the mucous membrane lining the inside of the uterine body-the endometrium, through the abnormal...
13.
Aebisher D, Woznicki P, Czarnecka-Czapczynska M, Dynarowicz K, Szliszka E, Kawczyk-Krupka A, et al.
Int J Mol Sci
. 2024 Aug;
25(16).
PMID: 39201395
Gliomas account for 24% of all the primary brain and Central Nervous System (CNS) tumors. These tumors are diverse in cellular origin, genetic profile, and morphology but collectively have one...
14.
Aebisher D, Szpara J, Bartusik-Aebisher D
Int J Mol Sci
. 2024 Aug;
25(15).
PMID: 39125828
Over the past decades, medicine has made enormous progress, revolutionized by modern technologies and innovative therapeutic approaches. One of the most exciting branches of these developments is photodynamic therapy (PDT)....
15.
Aebisher D, Serafin I, Batog-Szczech K, Dynarowicz K, Chodurek E, Kawczyk-Krupka A, et al.
Pharmaceuticals (Basel)
. 2024 Jul;
17(7).
PMID: 39065781
Photodynamic therapy (PDT) is a promising cancer treatment method that uses photosensitizing (PS) compounds to selectively destroy tumor cells using laser light. This review discusses the main advantages of PDT,...
16.
Aebisher D, Przygorzewska A, Bartusik-Aebisher D
Curr Issues Mol Biol
. 2024 Jul;
46(7):7239-7257.
PMID: 39057071
Photodynamic therapy (PDT) can not only directly eliminate cancer cells, but can also stimulate antitumor immune responses. It also affects the expression of immune checkpoints. The purpose of this review...
17.
Wanczura P, Aebisher D, Wisniowski M, Kos M, Bukowski H, Golicki D, et al.
Healthcare (Basel)
. 2024 Jul;
12(13).
PMID: 38998893
Heart failure (HF) is a common clinical syndrome in which the cardiac systolic and/or diastolic functions are significantly insufficient, resulting in an inadequate pump function. Currently, it is one of...
18.
Aebisher D, Rogoz K, Mysliwiec A, Dynarowicz K, Wiench R, Cieslar G, et al.
Front Oncol
. 2024 May;
14:1373263.
PMID: 38803535
Cancer therapy, especially for tumors near sensitive areas, demands precise treatment. This review explores photodynamic therapy (PDT), a method leveraging photosensitizers (PS), specific wavelength light, and oxygen to target cancer...
19.
Wanczura P, Aebisher D, Iwanski M, Mysliwiec A, Dynarowicz K, Bartusik-Aebisher D
Biomedicines
. 2024 May;
12(5).
PMID: 38790923
Lipids, together with lipoprotein particles, are the cause of atherosclerosis, which is a pathology of the cardiovascular system. In addition, it affects inflammatory processes and affects the vessels and heart....
20.
Wanczura P, Aebisher D, Wisniowski M, Kos M, Bukowski H, Holownia-Voloskova M, et al.
J Clin Med
. 2024 May;
13(9).
PMID: 38731133
Heart failure (HF) is not only a common cardiovascular disease with a poor prognosis. Its prevalence in developed countries equals 1-2% of the general population of adults, while in Poland...